Approval · Notice of Compliance 17669 · 2016
KYPROLIS: Notice of Compliance 17669
Issued January 15, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17669
- Date
- January 15, 2016
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KYPROLIS | 02451034 | Marketed |
Medicinal ingredients
- CARFILZOMIB 60 MG per VIAL